[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100619145":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":10,"locations":10,"responsibleParty":20,"collaborators":10,"id":22,"slug":10,"hasResults":23,"nctId":24,"briefTitle":25,"officialTitle":25,"acronym":10,"eligibilityCriteria":26,"healthyVolunteers":23,"sex":27,"minAge":28,"maxAge":10,"enrollmentInfo":29,"targetDuration":10,"studyType":32,"phases":10,"briefSummary":33,"conditions":34,"keywords":10,"overallStatus":36,"whyStopped":10,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":10},{"fullName":5,"class":6},"March Biosciences Inc","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Open Observation",null,"All patients who previously received MB-105 on another study",[13],"Biological: MB-105",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"BIOLOGICAL","MB-105","This is an observational study with no study product administered because it is the LTFU study for patients who received the product in another study",[9],{"type":21,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100619145",false,"NCT07340814","A Long-term Follow-up Study of Patients Who Received MB-105","Inclusion Criteria:\n\nReceived MB-105 Signed informed consent Agree to transfer of samples from previous study Able to comply with study requirements\n\nExclusion Criteria:\n\nN\u002FA","ALL","18 Years",{"count":30,"type":31},40,"ESTIMATED","OBSERVATIONAL","This study is to fulfil the regulatory requirement for 15-year follow-up for patients treated with MB-105 in any study",[35],"Any Patient Treated With MB-105","NOT_YET_RECRUITING","2026-01-06",{"date":39,"type":40},"2026-01-14","ACTUAL",{"date":42,"type":31},"2026-02-27",{"date":44,"type":31},"2040-10-15",{"name":5,"class":6}]